Company Info

Number of Employees

457

Ticker

SNY (NYSE)

Revenue

$118.7

Visit Website

Sandoz

CDMO, Pharma Intermediates

Overview

Sandoz, a Novartis company, is a provider of generic pharmaceuticals. Sandoz Anti-Infectives & API has more than 60 years of experience in fermentation and downstream processing for production of APIs across various therapeutic areas. The company offers global manufacturing capabilities to customers looking for a partner in the manufacture of fermentation-derived and semi-synthetic molecules.

Company Services

Services/CapabilitiesCDMO

+ Biomanufacturing

cGMP Microbial Manufacturing
Vaccine Development & Manufacturing

+ Development Services

Analytical Development & Validation
Bioanalytical Services
Preformulation/Formulation
Process Development & Validation
Scale Up/Tech Transfer
Stability Testing

+ Drug Product Manufacturing

Cytotoxic / High Potency Compounds (OEL < 1µg/m3)
Lyophilized Products Manufacturing

+ Drug Substance Manufacturing

Advanced Intermediates

+ Packaging

Carton Packaging
Prefilled Syringes/Cartridges/Pen Devices

Company Info

Sandoz

Overview

Company Services

Services/CapabilitiesCDMO

Services/CapabilitiesPharma Intermediates

Contributions

Sandoz Announces Plans for Joint Investment to Help Strengthen Future of Antibiotics Manufacturing in Europe

Sandoz Announces Agreement to Acquire Aspen’s Japanese Operations

Sandoz Receives FDA Approval for Oncology Supportive Care Biosimilar Ziextenzo™

FDA Announces Voluntary Recall of Sandoz Ranitidine Capsules Following Detection of an Impurity

Sandoz Issues Voluntary Recall of Losartan

Sandoz Inc. Announces US FDA Approval of Pediatric Dose of SYMJEPI™ (Epinephrine)

Novartis Unloads Sandoz US Components

DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR® (SABER®-Bupivacaine)

CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc. (Sandoz)

Sandoz – Biocon Deal One More Sign That U.S. Biosimilars Have Arrived